Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating remote programming for cochlear implants during follow-up

Official title: Evaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up

Run by Advanced Bionics AG · NCT06894303 · Data updated 2026-11-12

This study is testing if remote programming for cochlear implants can help people hear as well as traditional in-office programming while also gathering their feedback on the experience.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment51 (estimated)
SponsorAdvanced Bionics AG
Industry-sponsored
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 3, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 20, 2026
Trial IDNCT06894303 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have been implanted with specific HiResolution Bionic Ear Systems and have at least six months of cochlear implant experience.

Probably not a fit

Patients with unrealistic expectations about the benefits of the device or those with potential device malfunctions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety and efficacy of remote programming for cochlear implants using the Target CI version 1.5 and the AB Remote Support app. It is a non-interventional, monocentric investigation that compares hearing outcomes from remote programming to traditional in-office programming. The study employs a non-inferiority design to determine if sentence recognition in noise is comparable between the two methods. Participants will provide feedback on their hearing experiences after using the remote programming feature.

Why it matters

Potential benefit: If successful, this study could enhance the convenience and accessibility of cochlear implant follow-up care for patients.

How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, making this a relatively novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to provide informed consent
* Ability to give feedback on hearing impressions
* Aged 18 years of age or older
* Implanted with a HiResolution Bionic Ear System (HiRes 90K or HiRes 90K Advantage or HiRes Ultra or HiRes Ultra 3D) on at least one side

  * Group 1 - Unilateral: no hearing device except contralateral routing of signals (CROS) device on the contralateral side
  * Group 2 - Bilateral: implanted on both sides
  * Group 3 - Bimodal: hearing aid on the contralateral side
* Minimum of six months of cochlear implant experience
* Minimum of one month experience with a Naída CI M or Sky CI M sound processor
* Fluent in French language
* Ability to be tested via speech perception test in noise
* Smartphone user

Exclusion Criteria:

* Clinical presentation indicative of potential implanted device malfunction
* Unrealistic expectations regarding potential benefits, risks and limitations of the investigational device as determined by the Investigator
* Unwillingness or inability of subject to comply with all investigational requirements as determined by the Investigator

Pregnancy and breast-feeding are not exclusion criteria.

Where it's running

  • Groupement Hospitalier Pitié Salpêtrière
    Paris, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.